{"transactions":[{"id":4629960,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Common Stock","published_at":"2026-10-05T20:11:29.000Z","date":"2026-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":3.94,"value":4125.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":43529,"source":{"system":"sec-edgar","filing":"0001193125-26-414123","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526414123/ownership.xml","form_type":"4"}},{"id":4618346,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-09-15T20:59:35.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":7.8415,"value":15683.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 to $7.90. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 3,800 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":9383,"source":{"system":"sec-edgar","filing":"0001193125-26-392093","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526392093/ownership.xml","form_type":"4"}},{"id":715653,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Common Stock","published_at":"2026-07-06T22:00:04.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":7.8,"value":8166.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":44576,"source":{"system":"sec-edgar","filing":"0001193125-26-296502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526296502/ownership.xml","form_type":"4"}},{"id":768203,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2026-05-21T21:05:25.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":12300,"derivative":{"exercise_price":9.15,"expiration_date":"2026-05-19","underlying":"Common Stock","underlying_shares":12300},"source":{"system":"sec-edgar","filing":"0001193125-26-234850","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526234850/ownership.xml","form_type":"4"}},{"id":768202,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-05-21T21:05:25.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2026, 3,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 8,600 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":11383,"source":{"system":"sec-edgar","filing":"0001193125-26-234850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526234850/ownership.xml","form_type":"4"}},{"id":792028,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Common Stock","published_at":"2026-05-05T23:05:35.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1047,"price":9.03,"value":9454.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":45623,"source":{"system":"sec-edgar","filing":"0001193125-26-207041","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526207041/ownership.xml","form_type":"4"}},{"id":846494,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-12T20:56:14.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":210000,"derivative":{"exercise_price":10.19,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001193125-26-104369","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526104369/ownership.xml","form_type":"4"}},{"id":846493,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:56:14.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":46670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a period of four years from January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. The RSUs will be settled in shares of Common Stock upon vesting."}],"balance_after":46670,"source":{"system":"sec-edgar","filing":"0001193125-26-104369","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000119312526104369/ownership.xml","form_type":"4"}},{"id":1053751,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Med & Dev Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-28T20:37:59.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":357177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"A fraction of the shares underlying such option equal to (x) the number of full months between August 11, 2025 (\"Vesting Commencement Date\") and the date on which a registration statement on Form S-8 is filed and effective with the Securities and Exchange Commission (the \"S-8 Filing Date\") divided by (y) 48 shall vest on the S-8 Filing Date, and 1/48th of the shares underlying such option shall vest each month thereafter on the day of the month corresponding to the Vesting Commencement Date (and if there is no suchcorresponding day for a month, then the vesting date shall be the last day of the applicable month) until 100% of the shares underlying such option is vested on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service the Issuer on each such vesting date."}],"balance_after":357177,"derivative":{"exercise_price":9.59,"expiration_date":"2035-08-25","underlying":"Common Stock","underlying_shares":357177},"source":{"system":"sec-edgar","filing":"0000950170-25-111997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017025111997/ownership.xml","form_type":"4"}},{"id":1127886,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-06-02T20:30:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":16000,"derivative":{"exercise_price":7.42,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-080312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017025080312/ownership.xml","form_type":"4"}},{"id":1127885,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-06-02T20:30:15.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":4800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2025, 4,800 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 4,800 unvested RSUs that were granted on May 30, 2025."}],"balance_after":7583,"source":{"system":"sec-edgar","filing":"0000950170-25-080312","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017025080312/ownership.xml","form_type":"4"}},{"id":1495388,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-03T20:28:35.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 30, 2024, 2,783 restricted stock units (\"RSUs\") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"source":{"system":"sec-edgar","filing":"0000950170-24-068013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000095017024068013/ownership.xml","form_type":"4"}},{"id":1509259,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-20T20:54:31.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant."}],"balance_after":2783,"derivative":{"exercise_price":45.92,"expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":2783},"source":{"system":"sec-edgar","filing":"0001209191-24-005671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000120919124005671/doc4.xml","form_type":"4"}},{"id":1882913,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-22T20:20:49.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest 100% on the one year anniversay from the date of grant."}],"balance_after":5300,"derivative":{"exercise_price":9.96,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001209191-23-031448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000120919123031448/doc4.xml","form_type":"4"}},{"id":1966458,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":32204,"kind":"person","name":"Ben Yong","position":1,"cik":"0001967669","reported_name":"Ben Yong","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2023-03-07T15:19:00.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":5307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":5307,"derivative":{"exercise_price":2.85,"expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":5307},"source":{"system":"sec-edgar","filing":"0001209191-23-016575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967669/000120919123016575/doc4.xml","form_type":"4"}}]}